Supilanas, Nicole S.
HRN: 14-91-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2025
CEFUROXIME 750MG (VIAL)
06/12/2025
06/19/2025
IV
750 Mg
Q8H
UTI
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines